Latest News
Acumen Pharmaceuticals, Inc.
- Acumen to present Alzheimer’s trial data at CTAD conference By Investing.com
- Acumen to present Alzheimer’s trial data at CTAD conference By Investing.com
- Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
- Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference
- As Results Approach, What Could the Market Be Overlooking in Unprofitable Small Caps GrafTech, Acumen Pharmaceuticals, Clearwater Paper, Civeo, Neighborhood Intelligence, TrueBlue, LiveWire, PAM Transportation Services, GSI Technology and Ultralif
- Does Acumen Pharmaceuticals (NASDAQ:ABOS) Have Enough Cash Runway Before Its October 26 Earnings Release?
- Acumen Pharmaceuticals (ABOS.US) will release its financial report before the market opens on October 26.
- Acumen Pharmaceuticals Q3FY26 Results: Earnings call set for Oct 26, 2026
- Acumen Pharmaceuticals to Report Third Quarter Financial Results on October 26, 2026
Headlines from the last 30 days, linking to the original publishers. See all market news →